Pangea Biomed
PrivateLast Round
Seed
Dec 15, 2022
Total Funding Raised
$19M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pangea Biomed operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in December 2022.
Pangea Biomed is a biotechnology company that has developed ENLIGHT, a computational platform using RNA analysis and machine learning to predict cancer therapy responses and personalize cancer care.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Medical AI, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pangea Biomed Comparables
Compare Pangea Biomed with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genialis | 81% | |
| Blank Bio | 78% | |
| Strata Oncology | 76% |
For institutional investors. Book with your work email.
Pangea Biomed Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 15, 2022 | ||||
| Seed | Apr 8, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pangea Biomed Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 559% MoM.
- Jun 18, 2026
Monthly visitors grew 2738% MoM, from 8 to 227.
For institutional investors. Book with your work email.
Pangea Biomed Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pangea Biomed's valuation, stock price, and market status.
Is Pangea Biomed a public or private company?
Pangea Biomed is a private company.
What is the current stock price of Pangea Biomed?
Pangea Biomed is a private company, so its shares have no public market price. Caplight tracks Pangea Biomed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pangea Biomed worth (valuation)?
Valuation information for Pangea Biomed is not publicly available.
Can I buy Pangea Biomed stock?
Pangea Biomed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pangea Biomed's last funding round?
Pangea Biomed's most recent funding round was Seed on December 15, 2022.
Who are the main investors in Pangea Biomed?
Key investors in Pangea Biomed include NFX.
Will Pangea Biomed IPO soon?
No public IPO plans have been announced for Pangea Biomed.
How can I track Pangea Biomed secondary market activity?
Caplight tracks bids, offers, and trades in Pangea Biomed's shares on secondary markets.